• Réf. :HematoStat.net ; 1 (1) : V11 Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia. Doi 10.3390/cancers13092095.

    Publié le : 9 juillet 2021